MiNK Therapeutics Q3 EPS $(0.50) Beats $(0.66) Estimate
Benzinga Newsdesk 4 hours ago
NewsEarningsEarnings Beats
MiNK Therapeutics (NASDAQ:INKT) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.66) by 24.24 percent. This is a 23.08 percent increase over losses of $(0.65) per share
MiNK Therapeutics (NASDAQ:INKT) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.66) by 24.24 percent. This is a 23.08 percent increase over losses of $(0.65) per share from the same period last year.